Cypher AI, a life science infrastructure startup, has successfully emerged from stealth mode, announcing a $2 million seed funding round led by MaC Venture Capital, with contributions from Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures.
Founded by former scientist and engineer Yaoyu Yang, PhD, in 2025, Cypher AI aims to address the inefficiencies in life science R&D by replacing outdated systems such as fragmented spreadsheets and disconnected Electronic Lab Notebooks (ELNs). The platform has already attracted significant early adoption, with over 800 scientists utilizing it for more than 100,000 lab and computational workflows across various biotech firms, including DropGenie and Bioqore.
The biotechnology sector has seen a surge in AI applications focused on drug discovery. However, operational challenges persist due to fragmented legacy systems that hinder research execution. Cypher AI's platform seeks to unify experiment design, execution, and analysis into a cohesive digital ecosystem, thereby enhancing laboratory reproducibility and scalability. Dr. Yang emphasizes that their AI-native platform is designed for modern scientific workflows, enabling researchers to move seamlessly from hypothesis to validated insights.
As the demand for agile and scalable research solutions grows, Cypher AI's infrastructure promises to redefine operational capabilities within biotech. The ability to support nonlinear growth without disrupting existing workflows represents a significant advancement for life sciences companies navigating complex research landscapes.